How Astrana Health, Inc. stacks up

ASTH · against 420 other Healthcare companies of similar size

Overall

52/ 100

Above the middle of the pack.

Ranked #197 of 421 · scores higher than 51% of peers

Bars: peers in each 10-point band of the overall score

76 peers with an overall score of 50–59, including ASTH · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#202 of 429Score 57 / 100 · beats 52%Growth#40 of 387Score 89 / 100 · beats 89%Profitability#239 of 422Score 46 / 100 · beats 43%Risk#368 of 431Higher relative risk · safety 15 · beats 15%

Ranking by overall score

Top 5 and the companies ranked around ASTH

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	BB Biotech AGBBZA.DE · Europe	3.1B EUR (≈$3.4B)	100		100	100	0 / 2
2	Lakefront Biotherapeutics NVLKFT · US-listed	2.1B USD	96	96	99	93	0 / 2
2	Zealand Pharma A/SZEAL.CO · Europe	15.6B DKK (≈$2.3B)	96	96	99	96	0 / 2
4	Innoviva, Inc.INVA · US-listed	1.5B USD	93	94	91	93	0 / 2
5	PharmaResearch Co., Ltd.214450.KQ · South Korea	2.29T KRW (≈$1.6B)	88	83	90	96	0 / 2
⋯
197	Ningbo Menovo Pharmaceutical Co., Ltd.603538.SS · China	6.7B CNY (≈$941M)	52	54	57	58	1 / 2
197	Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.603707.SS · China	13.2B CNY (≈$1.9B)	52	68	28	62	1 / 2
197	AlvotechALVO · US-listed	1.6B USD	52	46	94	59	2 / 2
197	Amphastar Pharmaceuticals, Inc.AMPH · US-listed	1.2B USD	52	85	33	67	2 / 2
197	Astrana Health, Inc.ASTH · US-listed	1.8B USD	52	57	89	46	2 / 2
197	Dermapharm Holding SEDMP.DE · Europe	1.9B EUR (≈$2.1B)	52	84	41	78	2 / 2
197	Prestige Consumer Healthcare Inc.PBH · US-listed	2.3B USD	52	80	25	73	2 / 2
197	Summerset Group Holdings LimitedSUM.NZ · Australia & NZ	1.6B NZD (≈$946M)	52	82	52	39	1 / 2
206	Jilin Aodong Pharmaceutical Group Co., Ltd.000623.SZ · China	20.7B CNY (≈$2.9B)	51	81	31	37	1 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…